You are here Home Resources and guidance Sponsors Ipsen Pty Ltd Regulatory activities for this sponsor. Listen Print Share LinkedIn (Twitter) Facebook Email Loading... Type Designation or determination (1) Prescription medicine registration (1) Date (-) 2022 (2) 2025 (13) 2024 (5) 2023 (9) 2021 (5) 2020 (2) 2019 (3) 2018 (9) 2015 (2) 2011 (1) 2010 (1) 2007 (1) 2006 (2) 2003 (3) 2000 (1) Search Filters applied:2022Clear all Sponsor content2 result(s) found, displaying 1 to 2 CABOMETYX (Ipsen Pty Ltd) 6 December 2022 Prescription medicine registration Active ingredients: cabozantinib (S)-malate. Notice for palovarotene (Ipsen Pty Ltd) 13 July 2022 Designation or determination Orphan drug
CABOMETYX (Ipsen Pty Ltd) 6 December 2022 Prescription medicine registration Active ingredients: cabozantinib (S)-malate.